Skip to main navigation
  • Twitter
  • Linkedin
  • Youtube

Top Nav

  • Careers
  • Contact Us
  • Sign Up for Alerts
Poseida

Corporate Menu & Investor Relations

  • Company
    • About Us
    • Leadership
    • Board Of Directors
  • Technology
    • Overview
    • PiggyBac DNA Modification
    • Cas-CLOVER Gene Editing
    • Gene Delivery
    • Additional Tools
    • Gene Engineering
  • Pipeline
    • Programs
    • CAR-T Strategy
    • New Gene Therapies
  • Patients
    • About CAR-T Therapy
    • Clinical Trials
  • Investors and Media
    • Press Releases
    • Events and Presentations
    • Publications
    • Financials & Filings
      • SEC Filings
    • Stock Info
      • Stock Quote & Chart
    • Email Alerts
    • Analysts
    • Corporate Governance
      • Documents & Charters
      • Board of Directors
      • Leadership
      • Committee Composition
    • IR Contact
  • Menu
Banner-inner

Investors

Investor Relations

  • Company
    • About Us
    • Leadership
    • Board Of Directors
  • Technology
    • Overview
    • PiggyBac DNA Modification
    • Cas-CLOVER Gene Editing
    • Gene Delivery
    • Additional Tools
    • Gene Engineering
  • Pipeline
    • Programs
    • CAR-T Strategy
    • New Gene Therapies
  • Patients
    • About CAR-T Therapy
    • Clinical Trials
  • Investors and Media
    • Press Releases
    • Events and Presentations
    • Publications
    • Financials & Filings
      • SEC Filings
    • Stock Info
      • Stock Quote & Chart
    • Email Alerts
    • Analysts
    • Corporate Governance
      • Documents & Charters
      • Board of Directors
      • Leadership
      • Committee Composition
    • IR Contact

Tools

  • Print Page
  • Email Page
  • RSS Feeds

IR Contact

IR Contact

Marcy Graham
Vice President, Corporate Affairs
Poseida Therapeutics
9390 Towne Centre Drive, Suite 200
San Diego, CA 92121
Phone: (858) 779-3100

 

Corporate Menu & Investor Relations

Company About Us Leadership Board Of Directors

Technology Overview PiggyBac DNA Modification Cas-CLOVER Gene Editing Gene Delivery Additional Tools Gene Engineering

Pipeline Programs CAR-T Strategy New Gene Therapies

Patients About CAR-T Therapy Clinical Trials

Investors and Media Press Releases Events and Presentations Publications Financials & Filings Stock Info Email Alerts Analysts Corporate Governance IR Contact

Copyright © 2020 Poseida Therapeutics, Inc. | All Rights Reserved

Footer

Privacy Policy Expanded Access Policy

Scroll to top